SYS-6005

N/A

Report date: 2025/04/22 20:00:06

Base Information

Drug NameSYS-6005
Drug Alias NameRB-164RB164SYS6005YSYS-6005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payload
Mechanisms of ActionAnti-Inactive tyrosine-protein kinase transmembrane receptor ROR1Tubulin polymerisation inhibitors
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Tubulin
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma, B-Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCSPC Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRadiance Biopharma IncCSPC Megalith Biopharmaceutical Co Ltd
Inactive CompaniesJushi Biopharmaceutical Co Ltd
Active IndicationsSolid tumoursHematologic NeoplasmsLymphoma, B-Cell +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A